Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
104.80    -2.40 (-2.24%)
Bid:
104.80
Ask:
106.00
Spread: 1.20 (1.145%)
Market Cap: £440.53m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

8 Dec 2011 07:00

RNS Number : 5528T
PZ CUSSONS PLC
08 December 2011
 



8 December 2011

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2011.

 

First half trading

 

The Group's businesses in its core markets of the UK, Indonesia and Nigeria have achieved continued momentum with good revenue growth in the period, however a continued high level of raw material costs and adverse exchange rate movement have impacted margins. In addition, trading conditions in Australia, and in the smaller markets of Greece, Thailand and the Middle East, have been challenging. As a result profit overall for the period has been below expectations.

 

The financial position of the Group is strong with negligible net borrowings at the end of the period.

 

Trading - Update

 

Europe

 

The UK washing and bathing division has experienced good revenue growth despite worsening consumer confidence although continued high levels of promotional activity in the retailers and high raw material prices have put some pressure on margins. New product launches in the period have been well received and include Carex 'Protect Plus' with a new technology that kills bacteria for up to two hours after use.

 

The newly formed beauty division, created following the acquisition of The Sanctuary and more recently St Tropez, has performed well with an increase in revenue and profit despite tougher trading conditions in all UK distribution channels. New product launches have been successful and include the Charles Worthington 'Salon at home' range which has experienced good sales rates since launch in September.

 

Performance in Poland has been robust with revenue and profit ahead of the prior period. Trading conditions in Greece have been difficult as a result of the domestic economic situation.

 

Asia

 

Revenue and profit in Australia are lower than the previous period due to competitive trading conditions in the retailers and high raw material costs.

 

Continued positive momentum in Indonesia has delivered another period of revenue and profit growth largely from the market leading Cussons Baby range.

 

Trading in the Middle East has been affected by social and political unrest in those territories. Supply from Thailand was affected by the recent floods although the situation is now returning to near normal.

 

Africa

 

In Nigeria, revenue growth in all business units has been strong as economic and political stability returns to the country following elections earlier this year. Continued high levels of raw material costs together with a weaker naira have, however, impacted margins in the period. The effect of higher cost of stock together with longer port clearance times have also lead to higher inventory levels as the territory enters peak trading season.

 

Construction of the palm oil refinery with Wilmar in Nigeria is on schedule with completion due by the end of the 2012 calendar year.

 

Performance in Ghana and Kenya has been robust and ahead of the prior period.

 

Directors

 

As announced last month, Helen Owers and Ngozi Edozien will join the board as non-executive directors on 1 January 2012.

 

Full year outlook

 

The trading environment will continue to be difficult given increasing pressures on consumer spending power in all markets, continued high levels of promotional activity in developed markets and the UK in particular, and ongoing high level of input costs.

 

Our focus remains on driving profitable growth for the year through continued brand renovation and margin improvement in all territories.

 

Our strong financial position will enable us to invest in attractive medium term growth opportunities in our core markets in Europe, Asia and Africa.

 

Interim Announcement

 

Interim results for the half year to 30 November 2011 will be announced on Tuesday 24th January 2012.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate, London EC2M 6XB.

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh - Finance Director

 

MHP Communications Tel: 020 3128 8100

John Olsen / James White

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGAAPUPGGAM
Date   Source Headline
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.